Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA-guanine transglycosylase (TGT) from Zymomonas mobilis is a homodimeric enzyme that plays a critical role in the post-transcriptional modification of tRNA. It catalyzes the site-specific replacement of guanine at the wobble position (G34) of tRNA(Asn, Asp, His, Tyr) with the precursor 7-aminomethyl-7-deazaguanine (preQ1), a key step in the biosynthesis of queuosine (UniProt: P28720). While Z. mobilis is a non-pathogenic bacterium, its TGT is highly homologous to the TGT found in Shigella species, making it a primary structural model for antibiotic drug discovery (PubMed: 10417330). In Shigella, TGT activity is essential for the translation of VirF, the master transcriptional activator of the virulence plasmid, which is required for the invasion of the human intestinal epithelium (PubMed: 12692131). Inhibition of TGT effectively disarms the pathogen by preventing the expression of its virulence machinery without necessarily killing the bacteria, potentially reducing the pressure for resistance (PubMed: 25654371). Numerous small-molecule inhibitors, particularly those based on the lin-benzoguanine scaffold, have been developed and characterized using the Z. mobilis enzyme as a surrogate (PubMed: 21417383).
Inhibition of the exchange of guanine with pre-queuosine (preQ1) at position 34 of tRNA, preventing the formation of queuosine-modified tRNA required for the translation of virulence factors.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA-guanine transglycosylase (Zymomonas mobilis) (TGT).